RSPF Invesco S&P 500 Equal Weight Financials ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| HOOD | 1.75% |
| IBKR | 1.57% |
| AXP | 1.56% |
| COIN | 1.52% |
| WFC | 1.51% |
| IVZ | 1.50% |
| MS | 1.49% |
| BAC | 1.49% |
| PYPL | 1.48% |
| PFG | 1.47% |
ETF Analysis
Fund Overview
Invesco S&P 500 Equal Weight Financials ETF (RSPF) currently reports 75 stock positions (subject to change), placing it in the moderately broad range by holdings breadth. The top line-up is HOOD (1.75%), IBKR (1.57%), AXP (1.56%), with HOOD as the largest single weight at 1.75%. Together, the top three holdings account for 4.88%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.
Profitability & Capital Efficiency
Looking at how effectively the underlying holdings deploy capital, ROIC is 15.82%, WACC is 7.42%, and the economic spread is 8.41%. On balance, the spread between ROIC and WACC is narrow, leaving little buffer but still pointing to net positive value generation. Supporting metrics show ROE at 20.15% and ROA at 5.35%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
From a pricing standpoint, the portfolio sits at trailing P/E of 15.41, forward P/E of 12.21, PEG of 1.55. The narrow spread between trailing and forward multiples implies earnings expectations are relatively stable — the portfolio is not being priced for an earnings inflection. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio reading of 1.35 suggests the portfolio's holdings carry less short-term financial cushion than the broader market average. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.
Margins & Cash Generation
Across the three margin layers, gross margin sits at 55.23%, operating margin at 30.71%, and free cash flow margin at 34.08%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins this strong typically indicate a combination of pricing power, cost discipline, and operating leverage. Free cash flow conversion is exceptional, indicating holdings that are self-funding and cash-generative well above average. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.
Growth & Forward Outlook
Two key indicators frame the near-term view: TTM revenue growth of 13.64% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 21.75%, where the target distribution indicates incremental upside rather than outsized repricing. The near-term return case is built on whether reported trends and analyst projections can remain close enough to make current prices look justified. Whether the setup resolves positively or negatively will depend as much on the macro backdrop as on the capacity of the underlying businesses to deliver against current estimates. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyBalancing the strengths against the areas of uncertainty, the weight of evidence favors an optimistic view with appropriate risk awareness.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.